Northrop Grumman FY2025 Q1 Financial Report: Revenue Decreased 6.6%, Net Income Halved

Executive Summary

Northrop Grumman Corporation reported its first quarter results for FY2025, reflecting a significant decline in revenue and net income compared to the prior year. Revenue decreased by 6.6%, from $10.13 billion in Q1 FY2024 to $9.47 billion in Q1 FY2025, primarily driven by lower sales in Space Systems. Net earnings also declined sharply by 49%, from $944 million to $481 million, indicating increased operational challenges and cost pressures. The company’s strategic focus on defense and aerospace sectors remains strong, but recent financials highlight the need for operational adjustments and risk management.

Key Metrics

Management Discussion and Analysis

Northrop Grumman’s Q1 FY2025 results reveal a challenging start to the fiscal year, with revenue and profit margins under pressure. The 6.6% decline in revenue is mainly attributable to reduced sales in Space Systems, which saw a drop of approximately 18%, from $3.15 billion to $2.57 billion. This decline reflects delays and cancellations in certain space-related contracts amid geopolitical tensions and budget reallocations. Operating income fell by 46.7%, impacted by increased costs associated with the B-21 program, which recognized an additional $477 million loss provision, and higher manufacturing expenses. Net income halved, primarily due to lower revenue and increased operational costs, despite ongoing cost control measures. The company continues to focus on defense contracts, with 84% of sales derived from U.S. government customers, emphasizing its reliance on government defense spending. Liquidity remains robust with $1.69 billion in cash and equivalents, although down significantly from prior periods, reflecting strategic share repurchases and debt repayments. The company is actively managing its debt portfolio, having issued $2.5 billion in senior notes in January 2024 and repaid $1.5 billion of maturing debt in January 2025. Risks include geopolitical uncertainties, regulatory investigations, and project execution delays, which could impact future performance.

Income Statement Analysis

Revenue decreased by 6.6%, from $10.13 billion in Q1 FY2024 to $9.47 billion in Q1 FY2025, mainly due to a decline in Space Systems sales. Gross profit margins slightly improved due to cost efficiencies, but overall operating income declined by 46.7%, from $1.07 billion to $573 million, impacted by higher manufacturing costs and a $477 million loss provision on the B-21 program. Net earnings fell by 49%, from $944 million to $481 million, with earnings per share dropping from $6.32 to $3.32. The company’s effective tax rate increased marginally from 16.5% to 16.8%, reflecting interest expenses on unrecognized tax benefits and research credits. The decline in profitability underscores the need for operational resilience and strategic adjustments in high-cost programs.

Balance Sheet Analysis

As of March 31, 2025, Northrop Grumman reported total assets of $48.47 billion, a slight decrease of 1.8% from $49.36 billion at year-end FY2024. Cash and cash equivalents declined sharply by 61.1%, from $4.35 billion to $1.69 billion, due to share repurchases and debt repayments. Accounts receivable increased by 41%, from $1.27 billion to $1.80 billion, reflecting higher unbilled receivables. Inventories rose modestly to $1.58 billion, indicating ongoing production activities. Total liabilities decreased slightly to $33.48 billion, with long-term debt reduced to $14.17 billion after repayment of $1.5 billion in January 2025. Shareholders’ equity declined marginally to $14.98 billion, representing a 2% decrease, primarily due to lower retained earnings. The company’s liquidity position remains solid, supported by manageable debt levels and substantial asset base, but the reduced cash reserves highlight the importance of cash flow management.

Cash Flow Analysis

Operating cash flow was negative by $1.57 billion in Q1 FY2025, primarily due to net earnings decline and increased working capital requirements, including higher receivables and inventories. Capital expenditures totaled $256 million, slightly below the prior year, supporting ongoing program investments. Cash used in investing activities was $252 million, mainly for property, plant, and equipment. Financing activities resulted in net outflows of $851 million, driven by debt repayments of $1.5 billion, share repurchases of $480 million, and dividends paid totaling $302 million. The company issued $2.5 billion in senior notes in January 2024, enhancing liquidity and funding strategic initiatives. Despite the cash burn, the company maintains a strong liquidity buffer, but ongoing operational challenges and strategic investments will require careful cash management moving forward.

Ratios & DuPont Analysis

Northrop Grumman’s net profit margin declined sharply from 9.3% in Q1 FY2024 to 5.1% in Q1 FY2025, reflecting lower net income and higher costs. Return on assets (ROA) decreased from 1.9% to 1.0%, indicating reduced asset efficiency. Return on equity (ROE) fell from 6.2% to 3.2%, driven by lower net earnings and marginal equity decline. Asset turnover remained stable at approximately 0.19, while the equity multiplier slightly decreased to 3.24, indicating stable leverage. The DuPont analysis underscores the impact of declining profitability on overall return metrics, emphasizing the need for operational improvements and cost controls.

Risk Factors

Key risks include geopolitical tensions affecting defense contracts, regulatory investigations related to U.S. government cost claims, project execution delays, and market competition. The company faces potential liabilities from environmental remediation and legal disputes, which could impact financial stability. Macro-economic factors such as inflation, interest rate fluctuations, and government budget constraints also pose risks to future revenue streams and profitability. Strategic reliance on U.S. government defense spending exposes the company to policy changes and budget reallocations that could affect long-term growth prospects.

Notes & Additional Commentary

Unusual items in Q1 FY2025 include a $477 million loss provision on the B-21 program, reflecting higher manufacturing costs and process changes. The sale of the IMS business is expected to generate a $150 million after-tax gain, contributing positively to future cash flows. The company’s realignment of divisions and ongoing cost management initiatives are aimed at stabilizing margins and enhancing operational efficiency. Share repurchases remain a key component of capital allocation, with $480 million spent in the quarter, reducing outstanding shares and supporting EPS growth. The company continues to evaluate environmental and legal contingencies, with no material adverse outcomes currently anticipated.

Investment Implications

While Northrop Grumman faces near-term headwinds from program cost overruns and geopolitical uncertainties, its strong backlog of $92.8 billion and dominant position in defense contracting provide a solid foundation for long-term stability. Investors should monitor the company’s execution on high-cost programs and its ability to control operational expenses. The strategic divestiture of non-core assets and disciplined capital allocation, including share repurchases, support shareholder value. Caution is advised due to the declining profitability metrics, but the company’s defense focus and backlog position suggest resilience and potential for recovery as project costs stabilize and new contracts are secured.